These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35085854)

  • 1. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021.
    Rotering T; Apollonio DE
    Int J Drug Policy; 2022 Apr; 102():103585. PubMed ID: 35085854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco Industry Influences in the Oklahoma Legislature.
    Matheny JD; Wagener TL; Anderson MP
    J Okla State Med Assoc; 2015 Nov; 108(11):441-9. PubMed ID: 26817060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State tobacco lobbyists and organizations in the United States: crossed lines.
    Goldstein AO; Bearman NS
    Am J Public Health; 1996 Aug; 86(8):1137-42. PubMed ID: 8712274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive.
    Costa H; Gilmore AB; Peeters S; McKee M; Stuckler D
    Tob Control; 2014 Nov; 23(6):473-8. PubMed ID: 25124165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian lobbyist registers are not serving the purposes they were designed for.
    Robertson N; Kypri K; Stafford J; Daube M; Avery M; Miller P
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S218-S222. PubMed ID: 28695571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries.
    Adams PJ; Rychert M; Wilkins C
    Addiction; 2021 Nov; 116(11):2939-2946. PubMed ID: 33739486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco industry allegations of "illegal lobbying" and state tobacco control.
    Bialous SA; Fox BJ; Glantz SA
    Am J Public Health; 2001 Jan; 91(1):62-7. PubMed ID: 11189827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tobacco industry's use of Wall Street analysts in shaping policy.
    Alamar BC; Glantz SA
    Tob Control; 2004 Sep; 13(3):223-7. PubMed ID: 15333876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco lobby political influence on US state legislatures in the 1990s.
    Givel MS; Glantz SA
    Tob Control; 2001 Jun; 10(2):124-34. PubMed ID: 11387532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of lobbying activity on tobacco issues in the Wisconsin legislature.
    Ahrens D; Jones N; Pfister K; Remington PL
    WMJ; 2011 Apr; 110(2):74-7. PubMed ID: 21560561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco Institute lobbying at the state and local levels of government in the 1990s.
    Morley CP; Cummings KM; Hyland A; Giovino GA; Horan JK
    Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I102-9. PubMed ID: 11893820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugary drinks taxation: industry's lobbying strategies, practices and arguments in the Brazilian Legislature.
    Mariath AB; Martins APB
    Public Health Nutr; 2022 Jan; 25(1):170-179. PubMed ID: 33820589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waiting for the opportune moment: the tobacco industry and marijuana legalization.
    Barry RA; Hiilamo H; Glantz SA
    Milbank Q; 2014 Jun; 92(2):207-42. PubMed ID: 24890245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When tobacco targets direct democracy.
    Laposata E; Kennedy AP; Glantz SA
    J Health Polit Policy Law; 2014 Jun; 39(3):537-64. PubMed ID: 24603083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tobacco industry, state politics, and tobacco education in California.
    Begay ME; Traynor M; Glantz SA
    Am J Public Health; 1993 Sep; 83(9):1214-21. PubMed ID: 8362994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions.
    Lopipero P; Bero LA
    Tob Control; 2006 Aug; 15(4):323-32. PubMed ID: 16885582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardised tobacco packaging: a health policy case study of corporate conflict expansion and adaptation.
    Hatchard JL; Fooks GJ; Gilmore AB
    BMJ Open; 2016 Oct; 6(10):e012634. PubMed ID: 27855104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada's Healthy Eating Strategy.
    Gaucher-Holm A; Mulligan C; L'Abbé MR; Potvin Kent M; Vanderlee L
    Global Health; 2022 May; 18(1):54. PubMed ID: 35619107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.